Harrow Health is trading 5.2% lower at $31.35 amid broader market pressure; no direct cause for its September 28 move has been established.
- Major indexes are lower as oil prices and Treasury yields climb after President Trump rejected Iran’s proposal. This backdrop may be contributing, but evidence does not establish a direct link to Harrow Health’s decline.
- No clear company-specific announcement explaining the September 28 move surfaced in the search. The latest company news found was its September 1 announcement about investor conferences.